Overview

Brain Morphometry in OA Patients Treated With Duloxetine

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This is a two week,single-blind study evaluating pain response and changes in brain imaging upon treatment with placebo in people with knee OA.
Phase:
N/A
Details
Lead Sponsor:
Northwestern University
Collaborator:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride